Paul M. Silva, SVP & Interim CFO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 1,289 shares at $193.00 ($249K) on 2019-02-06, disclosed to the SEC on 2019-02-07.
Seasonal sale ($249k) by SVP & Interim CFO — this insider has traded VRTX in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| VRTX | SELL | 2021-02-19 | $1.8M | — | Filing → |
| VRTX | SELL | 2021-02-16 | $586K | — | Filing → |
| VRTX | SELL | 2020-08-10 | $564K | — | Filing → |